DANZITEN vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. DANZITEN and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	SPRYCEL
Rating	70/100	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	DASATINIB
Manufacturer	Azurity	Bristol Myers Squibb
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Lymphoid Leukemia, Myeloid Leukemia

danziten sprycel

Rating

70/100

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

NILOTINIB TARTRATE

DASATINIB

Manufacturer

Azurity

Bristol Myers Squibb

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

Which is better-rated, Danziten or Sprycel?

By our independent rating, Sprycel scores higher — 3.6 vs 3.5 out of 5 for Danziten. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Danziten and Sprycel?

Danziten contains Nilotinib Tartrate, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.